Clinical Trials Browser

Terminated × Prostatic Neoplasms × Itraconazole × Clear all

NCT05679388 2024-09-19

A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients

Phase 1 Terminated

Prostatic Neoplasms

NCT01450683 2017-04-11

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Phase 2 Terminated

4 enrolled 4 charts

Neoplasm Metastasis, Prostatic Neoplasms